跳至主要内容
临床试验/PACTR202001579275333
PACTR202001579275333招募中未知

Combined Insulin-like Growth Factor Binding Protein-1 and Interleukin-6 versus Transvaginal Ultrasonographically Measured Cervical Length for Pre-induction Cervical Assessment at Term: A Double Blind Randomized Study

DR CHIGOZIE OKAFOR0 个研究点目标入组 72 人开始时间: 2020年1月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • 1. Term (37-42weeks) singleton pregnancy
  • 2. Primigravida or Nulliparous pregnant women
  • 3. Cephalic presenting fetus
  • 4. Presence of intact fetal membranes
  • 5. No contraindications to vaginal delivery

排除标准

  • 1. Preterm pregnancy
  • 2. Intra uterine fetal death
  • 3. Cephalopelvic disproportion
  • 4. Fetal abnormal lie
  • 5. Fetal abnormal presentation
  • 6. Multiple pregnancy
  • 7. Previous caeserean scar or uterine surgeries
  • 8. Preinduction fetal heart rate abnormalities

研究者

发起方
DR CHIGOZIE OKAFOR

相似试验

已完成
不适用
Premaquick Pre-induction Cervical Assessmen TrialPregnancy and Childbirth
PACTR201604001592143DR GEORGE ELEJE170
Enrolling By Invitation
不适用
Expression of insulin-like growth factors as a prognostic factor in solitary fibrous tumorsICD-10-CM Z85.110 Personal history of malignant carcinoid tumor of bronchus and lung
DRKS00021109niversitätsklinikum Freiburg Klinik für Thoraxchirurgie100
进行中(未招募)
不适用
Recombinant Human Insulin-like Growth Factor (rhIGF-1) and Growth Hormone (rhGH) Combination Therapy of Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and Poor Response to First Year of Growth Hormone Therapy: A Phase II, Prospective, Randomized, Open-label, Multi-Centre, Parallel Group Add-On Study Comparing a Flexible rhIGF-1 Dose and Fixed rhGH Dose vs. Fixed rhGHDose Therapy.Pre-Pubertal Children with Idiopathic Growth Hormone DeficiencyMedDRA version: 12.1Level: LLTClassification code 10056438Term: Growth hormone deficiency
EUCTR2010-020742-10-GBIpsen Pharma63
进行中(未招募)
不适用
Comparison of efficacy and safety of Nutropin (rhGH) associated with Increlex (rhIGF-1) vs Nutropin (rhGH) alone [COGROW].Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and with poor response after one year of treatment.MedDRA version: 13.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disorders
EUCTR2010-020742-10-SEIpsen Pharma63
进行中(未招募)
不适用
Comparison of efficacy and safety of Nutropin (rhGH) associated with Increlex (rhIGF-1) vs Nutropin (rhGH) alone [COGROW].Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and with poor response after one year of treatment.MedDRA version: 13.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disorders
EUCTR2010-020742-10-FIIpsen Pharma63